Psilocybin desynchronizes the human brain
Top Cited Papers
Open Access
- 17 July 2024
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 632 (8023) , 131-138
Abstract
A single dose of psilocybin, a psychedelic that acutely causes distortions of space–time perception and ego dissolution, produces rapid and persistent therapeutic effects in human clinical trials1–4. In animal models, psilocybin induces neuroplasticity in cortex and hippocampus5–8. It remains unclear how human brain network changes relate to subjective and lasting effects of psychedelics. Here we tracked individual-specific brain changes with longitudinal precision functional mapping (roughly 18 magnetic resonance imaging visits per participant). Healthy adults were tracked before, during and for 3 weeks after high-dose psilocybin (25 mg) and methylphenidate (40 mg), and brought back for an additional psilocybin dose 6–12 months later. Psilocybin massively disrupted functional connectivity (FC) in cortex and subcortex, acutely causing more than threefold greater change than methylphenidate. These FC changes were driven by brain desynchronization across spatial scales (areal, global), which dissolved network distinctions by reducing correlations within and anticorrelations between networks. Psilocybin-driven FC changes were strongest in the default mode network, which is connected to the anterior hippocampus and is thought to create our sense of space, time and self. Individual differences in FC changes were strongly linked to the subjective psychedelic experience. Performing a perceptual task reduced psilocybin-driven FC changes. Psilocybin caused persistent decrease in FC between the anterior hippocampus and default mode network, lasting for weeks. Persistent reduction of hippocampal-default mode network connectivity may represent a neuroanatomical and mechanistic correlate of the proplasticity and therapeutic effects of psychedelics.Keywords
All Related Versions
This publication has 125 references indexed in Scilit:
- Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA, 2023
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use DisorderJAMA Psychiatry, 2022
- Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry, 2021
- Behavioral Neurobiology of Psychedelic Drugs2018
- Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy AdultsClinical Pharmacokinetics, 2017
- The effects of methylphenidate on whole brain intrinsic functional connectivityHuman Brain Mapping, 2014
- Statistical improvements in functional magnetic resonance imaging analyses produced by censoring high‐motion data pointsHuman Brain Mapping, 2013
- Multiband multislice GE‐EPI at 7 tesla, with 16‐fold acceleration using partial parallel imaging with application to high spatial and temporal whole‐brain fMRIMagnetic Resonance in Medicine, 2010
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significancePsychopharmacology, 2006
- Enhancement of BOLD-contrast sensitivity by single-shot multi-echo functional MR imagingMagnetic Resonance in Medicine, 1999